🏦 Institutional fund buys Ripple equity—not XRP—as private-market interest grows 🏦
A new SEC filing shows Kinetics Internet Portfolio holding approximately $150,000 worth of private Ripple shares, offering direct exposure to Ripple Labs rather than the XRP token.
🔑 Key points
🔹 Ripple shares were purchased: The fund owns Class A common shares in Ripple Labs.
🔹 Position is small: The holding is estimated at roughly $150,000 inside a fund with approximately $275 million in assets.
🔹 Filing reflects June 30 holdings: The information became public in August because of regulatory reporting delays.
🔹 Equity is separate from XRP: Ripple stock represents ownership in the company, while XRP is a separate digital asset with different rights and risks.
🔹 Private-market access was used: Because Ripple remains private, the fund reportedly acquired the shares through an over-the-counter platform for accredited investors.
🔹 Ripple’s private valuation is significant: The company’s recent $750 million tender offer reportedly valued Ripple at approximately $50 billion.
🔹 IPO speculation is returning: Ripple CEO Brad Garlinghouse has shifted from rejecting an IPO to taking a more neutral position.
🔹 Institutional demand may be arriving early: Investors can gain Ripple exposure through private shares without waiting for a public listing.
🔎 Why it matters
🔹 This filing shows that institutional investors may want exposure to Ripple’s payments, custody, and infrastructure business—not necessarily to XRP itself.
🔹 A Ripple equity investment does not automatically create buying pressure for XRP.
🔹 The company’s valuation depends on revenue, acquisitions, institutional contracts, and future public-market access, while XRP depends on market demand, liquidity, utility, and token economics.
🔹 The $150,000 position is too small to prove a broad institutional rush, but it signals that private Ripple shares are becoming investable for qualified funds.
🎯 Bottom line: The important distinction is Ripple versus XRP. An institutional fund has taken a small direct stake in Ripple Labs, betting on the company’s private-market growth and potential IPO—not buying XRP. That may be positive for Ripple’s corporate narrative, but it should not be misrepresented as direct institutional accumulation of the token.
https://u.today/ripple-not-xrp-new-sec-filings-reveal-275-million-funds-private-stock-position/